Project Overview 

Generate high-quality evidence to support pricing and reimbursement decisions in oncology and rare diseases across multiple markets.

Services Provided 

• Development and adaptation of cost-effectiveness and budget impact models.
• Integration of real-world data from clinical practice and observational studies.
• Application of propensity score methods (matching, weighting) for indirect treatment comparisons.
• Quantitative bias analysis to assess residual confounding.
• Meta-analyses and synthesis of clinical and economic evidence.
• Automation of reporting for HTA submissions.

Deliverables & Benefits 

• Country-specific models tailored for HTA submissions.
• Transparent and reproducible methodology using R and SAS.
• Evidence-based support for pricing negotiations and value dossiers.
• Identification of data gaps and strategic recommendations.
• Submission-ready technical reports and visual summaries.

Why Choose Lucid Analytics? 

With a deep understanding of life sciences and cutting-edge AI expertise, Lucid Analytics supports clients in accelerating innovation and driving impactful R&D outcomes.

Ready to Transform Your Data? 

Interested in how we can help with your next project? Contact us today to explore how data can drive your R&D success.